N-butyl cyanoacrylate in the treatment of venous insufficiency-the effect of embolisation with ablative polymerisation

被引:26
作者
Calik, Eyup Serhat [1 ]
Arslan, Umit [1 ]
Ayaz, Firat [2 ]
Tort, Mehmet [1 ]
Yildiz, Ziya [1 ]
Aksu, Volkan [3 ]
Onk, Oruc Alper [4 ]
Limandal, Husnu Kamil [1 ]
Ekingen, Evren [5 ]
Dag, Ozgur [1 ]
Kaygin, Mehmet Ali [1 ]
Erkut, Bilgehan [1 ]
机构
[1] Erzurum Training & Res Hosp, TR-25750 Erzurum, Turkey
[2] Diyarbakir Gazi Yasargil Training & Res Hosp, Izmir, Turkey
[3] Ardahan State Hosp, Izmir, Turkey
[4] Erzincan Univ, Fac Med, Izmir, Turkey
[5] Batman Reg State Hosp, Izmir, Turkey
关键词
Chronic venous insufficiency; varicose veins; treatment; embolisation; cyanoacrylate; GREAT SAPHENOUS-VEIN; 1ST HUMAN USE; RADIOFREQUENCY ABLATION; FOAM SCLEROTHERAPY; THERMAL ABLATION; LASER-ABLATION; ADHESIVE; TRIAL; 2-CYANOACRYLATE; MULTICENTER;
D O I
10.1024/0301-1526/a000531
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Background: The primary objective of this multicentre prospective observational study was to evaluate the early results of a new non-thermal embolisation method using N-butyl cyanoacrylate in venous insufficiency. Patients and methods: A total of 181 patients with a varicose vein diagnosis were treated with the VariClose: Vein Sealing Systems at four different centres. The protocol included physical and colour Doppler ultrasonography examination, venous clinical severity score and quality of life assessment before and after the procedure on days 1 and 7 and at months 1, 3 and 6. Clinical recovery was evaluated by comparing the venous clinical severity score and the quality of life assessment before and after the procedure. Results: In total, 215 embolisation procedures were successfully completed on 181 patients (110 female) with a mean age of 37.6 +/- 13.2 years (range 18 - 72 years). The 215 procedures consisted of 25 bilateral applications on 206 great saphenous veins and 9 small saphenous veins. The average pre-interventional diameter of great saphenous veins was 6.5 +/- 1.4 mm (4.3 - 14 mm), and the mean diameter of small saphenous veins was 5.2 +/- 1.3 mm (3.8 - 8.6 mm). The average length of the sealed vein segments was 31.6 +/- 6.1 cm (23 - 70 cm), and the average N-butyl cyanoacrylate usage for the patient was 0.9 ml (0.7 - 2.1 ml). The procedural occlusion rate was 100 %. Post-operative pain was observed in 11 patients (6.1 %), and thrombophlebitis was observed in 1 patient (0.5 %). No total recanalisation was observed. Five (2.7 %) partial recanalisations were observed at the 6 month follow-up. The 6 month total occlusion rate was 97.2 %. Conclusions: This new tumescent-free non-thermal embolisation method can be applied safely with high success rates.
引用
收藏
页码:241 / 246
页数:6
相关论文
共 28 条
[1]   Two-year follow-up of first human use of cyanoacrylate adhesive for treatment of saphenous vein incompetence [J].
Almeida, Jose I. ;
Javier, Julian J. ;
Mackay, Edward G. ;
Bautista, Claudia ;
Cher, Daniel J. ;
Proebstle, Thomas M. .
PHLEBOLOGY, 2015, 30 (06) :397-404
[2]  
Almeida JI, 2013, J VASC SURG-VENOUS L, V1, P174, DOI [10.1016/j.jvsv.2012.09.010, 10.1016/j.jvsv.2012.10.006]
[3]   Cyanoacrylate Adhesive for the Closure of Truncal Veins: 60-Day Swine Model Results [J].
Almeida, Jose I. ;
Min, Robert J. ;
Raabe, Rod ;
McLean, D. J. ;
Madsen, Monte .
VASCULAR AND ENDOVASCULAR SURGERY, 2011, 45 (07) :631-635
[4]   Radiofrequency Endovenous ClosureFAST versus Laser Ablation for the Treatment of Great Saphenous Reflux: A Multicenter, Single-blinded, Randomized Study (RECOVERY Study) [J].
Almeida, Jose I. ;
Kaufman, John ;
Goeckeritz, Oliver ;
Chopra, Paramjit ;
Evans, Martin T. ;
Hoheim, Daniel F. ;
Makhoul, Raymond G. ;
Richards, Tim ;
Wenzel, Christian ;
Raines, Jeffrey K. .
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2009, 20 (06) :752-759
[5]   Mechanisms of disease:: Chronic venous disease [J].
Bergan, John J. ;
Schmid-Schoenbein, Geert W. ;
Smith, Philip D. Coleridge ;
Nicolaides, Andrew N. ;
Boisseau, Michel R. ;
Eklof, Bo .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (05) :488-498
[6]  
BROTHERS MF, 1989, AM J NEURORADIOL, V10, P777
[7]  
Calvo WJ, 2001, AM J NEURORADIOL, V22, P691
[8]   Revision of the CEAP classification for chronic venous disorders:: Consensus statement [J].
Eklöf, B ;
Rutherford, RB ;
Bergan, JJ ;
Carpentier, PH ;
Gloviczki, P ;
Kistner, RL ;
Meissner, MH ;
Moneta, GL ;
Myers, K ;
Padberg, FT ;
Perrin, M ;
Ruckley, CV ;
Smith, PC ;
Wakefield, TW .
JOURNAL OF VASCULAR SURGERY, 2004, 40 (06) :1248-1252
[9]   The care of patients with varicose veins and associated chronic venous diseases: Clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum [J].
Gloviczki, Peter ;
Comerota, Anthony J. ;
Dalsing, Michael C. ;
Eklof, Bo G. ;
Gillespie, David L. ;
Gloviczki, Monika L. ;
Lohr, Joann M. ;
McLafferty, Robert B. ;
Meissner, Mark H. ;
Murad, M. Hassan ;
Padberg, Frank T. ;
Pappas, Peter J. ;
Passman, Marc A. ;
Raffetto, Joseph D. ;
Vasquez, Michael A. ;
Wakefield, Thomas W. .
JOURNAL OF VASCULAR SURGERY, 2011, 53 :2S-48S
[10]   Recurrent varicose veins: Sonography-based re-examination of 210 patients 14 years after ligation and saphenous vein stripping [J].
Hartmann, K ;
Klode, J ;
Pfister, R ;
Toussaint, M ;
Weingart, I ;
Waldermann, F ;
Hartmann, M .
VASA-JOURNAL OF VASCULAR DISEASES, 2006, 35 (01) :21-26